Rainbow Children's Medicare Limited (NSE:RAINBOW)
India · Delayed Price · Currency is INR | Market Cap | 139.10B +2.0% |
| Revenue (ttm) | 17.03B +12.4% |
| Net Income | 2.78B +14.3% |
| EPS | 27.41 +15.0% |
| Shares Out | 101.56M |
| PE Ratio | 49.97 |
| Forward PE | 42.33 |
| Dividend | 3.50 (0.25%) |
| Ex-Dividend Date | Jul 21, 2026 |
| Volume | 66,504 |
| Open | 1,395.00 |
| Previous Close | 1,380.30 |
| Day's Range | 1,351.20 - 1,395.00 |
| 52-Week Range | 1,084.00 - 1,645.70 |
| Beta | 0.13 |
| Analysts | Strong Buy |
| Price Target | 1,586.15 (+15.81%) |
| Earnings Date | May 23, 2026 |
About NSE:RAINBOW
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children’s Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, su... [Read more]
Financial Performance
In fiscal year 2026, NSE:RAINBOW's revenue was 17.03 billion, an increase of 12.35% compared to the previous year's 15.16 billion. Earnings were 2.78 billion, an increase of 14.34%.
Financial StatementsNews
Rainbow Children's Medicare Transcript: Q4 25/26
Q4 FY26 saw record revenue and capacity addition, with 24% revenue growth and strong operational metrics. Over 900 beds are in the pipeline, all funded internally, and the company targets 20% growth in FY27 while maintaining margins.
Rainbow Children's Medicare Quarterly report: Q4 2026
Rainbow Children's Medicare has published its Q4 2026 quarterly earnings report on May 25, 2026.
Rainbow Children's Medicare Slides: Q4 2026
Rainbow Children's Medicare has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 25, 2026.
Rainbow Children's Medicare Transcript: Q3 25/26
Q3 FY26 saw 12% revenue growth and strong new unit ramp-up, despite seasonal volume softness and increased competition. Occupancy was 47.2%, with a focus on driving this to 55-60% next year through digital, marketing, and specialty expansion. Cash reserves and capex plans remain robust.
Rainbow Children's Medicare Quarterly report: Q3 2026
Rainbow Children's Medicare has published its Q3 2026 quarterly earnings report on January 28, 2026.
Rainbow Children's Medicare Slides: Q3 2026
Rainbow Children's Medicare has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 28, 2026.
Rainbow Children's Medicare Transcript: Q2 25/26
Q2 FY26 saw 6.5% revenue growth but lower occupancy due to seasonality, with strong specialty and IVF growth. Integration of new acquisitions and hospital expansions continue, supported by a robust net cash position and a 20% revenue CAGR target over the next 2–3 years.
Rainbow Children's Medicare Quarterly report: Q2 2026
Rainbow Children's Medicare has published its Q2 2026 quarterly earnings report on November 13, 2025.
Rainbow Children's Medicare Slides: Q2 2026
Rainbow Children's Medicare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 13, 2025.
Rainbow Children's Medicare Transcript: Q1 25/26
Revenue grew 7% YoY to INR 353 crores, with EBITDA up 11% and PAT up 35%. Expansion continued via acquisition and new projects, while mature hospitals saw muted volumes but strong specialty mix. Guidance remains for late teens to 20% revenue growth, with robust cash reserves and asset-light expansion.
Rainbow Children's Medicare Quarterly report: Q1 2026
Rainbow Children's Medicare has published its Q1 2026 quarterly earnings report on July 28, 2025.
Rainbow Children's Medicare Slides: Q1 2026
Rainbow Children's Medicare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 28, 2025.